The Legal 500: Pharmaceutical Advertising Comparative Guide 2022
Written By
The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.
Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.
The Q&A template for each chapter has been provided by Sally Shorthose.
Read our overview of Pharmaceutical Advertising laws and regulations applicable in:
Read the French chapter here
Read the German chapter here
Read the UK chapter here
The Q&A template for each chapter has been provided by Sally Shorthose.
Read our overview of Pharmaceutical Advertising laws and regulations applicable in:
Read the French chapter here
Read the German chapter here
Read the UK chapter here
Latest insights
More Insights
China’s Data and Privacy Regime for the Civil Aviation Sector is Under Design: An Initial Exploration of Regulatory Blueprint (Part II)
Jul 25 2024